Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Lupus ; 10(8): 571-5, 2001.
Artigo em Inglês | MEDLINE | ID: mdl-11531000

RESUMO

Choroidal involvement in systemic lupus erythematosus (SLE) occurs infrequently. We report a 45-y-old woman with bilateral chorioretinopathy associated with SLE. Diagnosis was performed using indirect ophthalmoscopy, retinal fluorescein angiography (FA) and green indocianin angiography (ICG). In this patient chorioretinopathy and discoid-like plaque of the lids represented the only signs of SLE progression after 15 y of apparent remission of systemic disease.


Assuntos
Coriorretinite/patologia , Pálpebras/patologia , Lúpus Eritematoso Sistêmico/patologia , Coriorretinite/etiologia , Corantes , Progressão da Doença , Feminino , Angiofluoresceinografia , Humanos , Verde de Indocianina , Lúpus Eritematoso Sistêmico/complicações , Pessoa de Meia-Idade
2.
Eur J Ophthalmol ; 10(4): 332-4, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-11192843

RESUMO

PURPOSE: To assess the clinical efficacy of ibopamine eye drops in severe hypotony secondary to chronic progressive uveitis. METHODS: Case report. A 47-year-old man with a 37-year history of diffuse uveitis and severe refractory hypotony was treated with topical 2% ibopamine (Trazyl) six times a day. Intraocular pressure, visual acuity, visual field and side effects were recorded during 15 months of follow-up. RESULTS: IOP, visual acuity and visual field increased after four days of therapy and lasted for two months when the drug was suspended because of the onset of filamentous keratopathy. A new course of treatment with 2% ibopamine eye drops in a different solvent (BSS) resulted in a stable increase in IOP, VA and visual field, with no side effects in a follow-up of 13 months. CONCLUSIONS: Ibopamine 2% eye drops in BSS solvent seem effective in the treatment of uveitis-related hypotony.


Assuntos
Desoxiepinefrina/análogos & derivados , Desoxiepinefrina/uso terapêutico , Agonistas de Dopamina/uso terapêutico , Pressão Intraocular/efeitos dos fármacos , Hipotensão Ocular/tratamento farmacológico , Uveíte/complicações , Doença Crônica , Humanos , Masculino , Pessoa de Meia-Idade , Hipotensão Ocular/etiologia , Soluções Oftálmicas , Acuidade Visual/efeitos dos fármacos , Campos Visuais/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA